Podcast: CEO Of India's mRNA Pioneer Gennova On Cancer Vaccines, VC Interest
Pan-Coronavirus Vaccine In The Works
Founder CEO Sanjay Singh tells Scrip about Gennova Biopharma's preliminary talks with investors looking to grab a piece of the action post approval of its mRNA vaccine against COVID-19. As the company considers use of the technology in making vaccines against cancer and infectious diseases, it will also expand manufacturing
